Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Simulations Plus, Inc.NASDAQ: SLP

Net Margin · Q2 FY2026 · quarter ended Feb 2026

Net margin widens to 18.7%

Net margin was 18.7% in Q2 FY2026, up 5.0 pp from a year earlier. On a trailing-twelve-month basis it was -78.0%, down 87.2 pp year over year. Over 3 fiscal years it narrowed by 104.9 pp.

Context

  • Net margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 3 analysts of 22.1% for the fiscal year ending Aug 2026, up from -81.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterFeb 2026
18.7%+15.0 pp QoQ
Last fiscal yearAug 2025
-81.7%-96.0 pp YoY
LTMFeb 2026
-78.0%-87.2 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.0 pp+353.0 pp+348.1 pp
1 year-96.0 pp+103.9 pp+199.8 pp
3 years-104.9 pp+104.7 pp+209.6 pp
5 years+108.5 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-81.7%
Year-over-year change
-96.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How SLP compares with its peers on the latest reported figures

  • SLP's LTM Feb 2026 net margin of -78.0% is the 5th highest of the 10 companies compared; the peer median is -98.8%.
  • Its year-over-year change of -87.2 pp is the 7th highest of 10, against a peer median of -2.4 pp.
  • Over three fiscal years its change of -104.9 pp compares with a peer median of -7.5 pp.
SLP Competitors Peer median
Net Margin for SLP and competitors
Company Period LTM level YoY 3-year change
NRCNational Research CorporationLTM Mar 20266.5% -10.6 pp-12.5 pp
OPRXOptimizeRx CorporationLTM Mar 20266.4% +22.7 pp+23.0 pp
AGLAgilon Health, Inc.LTM Mar 2026-6.4% -2.4 pp-2.4 pp
DHDefinitive Healthcare Corp.LTM Mar 2026-71.5% +134.6 pp-54.3 pp
SLPSimulations Plus, Inc.LTM Feb 2026-78.0% -87.2 pp-104.9 pp
CLLSCellectis S.A.LTM Mar 2026-98.8% +28.3 pp+461.0 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-99.7% -1.2 pp+81.6 pp
ACIUAC Immune S.A.LTM Mar 2026-1788.8% -1604.7 pp-173.6 pp
KRROKorro Bio, Inc.LTM Mar 2026-2954.1% -1141.0 pp—
NAKANakamoto Inc.LTM Mar 2026-7397.8% -7220.8 pp-2800.6 pp
ANROAlto Neuroscience, Inc.FY2025— ——
Peer median (excluding SLP) -98.8%-2.4 pp-7.5 pp

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Revenue46.47M53.91M59.58M70.01M79.18M
Cost of Revenue10.6M10.82M11.63M26.86M32.96M
Gross Profit35.87M43.08M47.95M43.15M46.22M
Gross Margin77.2%79.9%80.5%61.6%58.4%
Research & Development4.05M3.21M4.5M5.75M6.88M
Selling, General & Admin20.57M24.97M34.72M31.27M32.85M
Operating Expenses24.61M28.17M39.22M37.02M116.95M
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
EBITDA14.7M18.69M13.07M18.08M14.7M
EBITDA Margin31.6%34.7%21.9%25.8%18.6%
Operating Income11.25M14.91M8.73M6.13M(70.73M)
Operating Margin24.2%27.7%14.6%8.8%-89.3%
Interest Income201K717K4.13M4.38M722K
Interest Expense22K0000
Other Income / Expenses(168K)204K2.97M6.28M1.35M
Income Before Tax11.09M15.12M11.7M12.41M(69.38M)
Pre-Tax Margin23.9%28.0%19.6%17.7%-87.6%
Income Tax Expense1.3M2.63M1.73M2.46M(4.66M)
Net Income9.78M12.48M9.96M9.95M(64.72M)
Net Margin21.1%23.2%16.7%14.2%-81.7%
EPS (Basic)0.490.620.500.50(3.22)
EPS (Diluted)0.470.600.490.49(3.22)
Weighted Avg Shares20.05M20.2M20.08M19.99M20.1M
Weighted Avg Shares (Diluted)20.74M20.75M20.47M20.3M20.1M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.